# Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics

> **NCT05736029** · — · RECRUITING · sponsor: **OncoHost Ltd.** · enrollment: 350 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Healthy

## Interventions

- **OTHER:** blood, stool and tissue samples collection

## Key facts

- **NCT ID:** NCT05736029
- **Lead sponsor:** OncoHost Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-07
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-06-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05736029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05736029, "Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05736029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*